Who this is written for. Licensed prescribers (physicians, nurse practitioners, physician assistants) who want a turnkey channel for compounded medications without standing up their own pharmacy relationships from scratch.

What Crystal Clear is

Crystal Clear is a coordinator between licensed prescribers, a licensed 503A compounding pharmacy partner, and the patients who need access to compounded therapies. We are not a pharmacy and we are not a prescriber. Our job is to make the connection frictionless so the prescriber does what only a prescriber can do (the clinical evaluation and the prescription) and the pharmacy does what only a pharmacy can do (the compounding and the dispensing).

What you get

• A 503A pharmacy partner ready to fulfill. No vetting your own compounder, no negotiating individual MOUs, no quality-control overhead. The partner is licensed across more than 25 states and growing.
• A current formulary. Peptides, GLP-1s, injectables, hormone optimization, and NanoNAD formulations ready to prescribe. New compounds are added when there is demand and they fit the partner's capabilities.
• Cold-chain delivery infrastructure. The pharmacy ships directly to patients with appropriate temperature handling. You do not coordinate logistics.
• Patient-facing acquisition. Crystal Clear markets the catalog to potential patients and routes consults to network providers. You can opt into receiving consult traffic, opt out, or use the network only for your existing patients. Your call.
• Clean separation of roles. Crystal Clear never touches PHI on the marketing site. The clinical relationship is between you and the patient, with the pharmacy as the licensed dispensing party.

Patient flow

From the network's point of view, a patient typically arrives in one of three ways:

1. Inbound consult. A patient browses the catalog, submits a consult request, and gets routed to a network prescriber for evaluation.
2. Existing patient. A clinician already working with a patient writes a prescription that flows through Crystal Clear's 503A partner instead of the prescriber's previous channel.
3. Partner-share track. A sales partner or referrer brings a patient through one of the partner-specific landing pages. The patient still goes through a network prescriber for evaluation.

The clinical evaluation is identical in all three cases. What changes is how the patient arrived.

How revenue works

Two revenue streams typically apply, and the specifics are confirmed during onboarding:

• Consult fees. When you evaluate a patient, the consult is your professional service. The fee structure depends on whether the consult was inbound through Crystal Clear or part of your existing practice.
• Partnership-tier pricing on the medication itself. Network providers receive preferred pricing on the compound itself, which lets you build a margin into a bundle if your practice charges for the medication directly. Some providers prefer the simpler model where the patient pays the pharmacy directly and the prescriber bills only the consult.

Both models are supported. Practices that want to bill the medication and consult as a single bundle can do so at partnership-tier pricing. Practices that prefer the patient pays the pharmacy directly can do that too. We can walk through both during onboarding.

Who this is for

• Aesthetics, wellness, longevity, and integrative practices already prescribing compounded medications and looking for a cleaner pharmacy relationship.
• Telehealth-forward practices that need a 503A partner with a wide state licensure footprint.
• Solo practitioners who want a turnkey compound formulary without the overhead of vetting and contracting their own pharmacy.
• Group practices considering a centralized compounded-medication channel for multiple prescribers under one roof.

If you primarily prescribe FDA-approved manufactured drugs and never write compounded prescriptions, the network is not currently a fit and we will say so.